Skip to content
Research Article Open access CC BY 4.0

Successful Treatment with Dapsone for Refractory Immune Thrombocytopenia

Yasuhiro Maeda, Kenta Yamamoto, Ayano Fukui, Go Eguchi, Terufumi Yamaguchi

International Journal of Medical and Pharmaceutical Case Reports · pp. 57–60 · Published 22 Oct 2014

10.9734/IJMPCR/2015/13139

Abstract

In adult with immune thrombocytopenia (ITP), it has been known that steroids have been used as a first-line therapy. The therapy induced remission in more than 60% of patients. Here, we evaluated the results of dapsone for a steroid-resistant ITP patient. Further, dapsone has been reported to emerge as a safe and inexpensive therapy for chronic ITP. In this case, we showed a relationship between platelet count and grade of hemolysis by treatment with dapsone.

ITP drug-resistance dapsone hemolysis

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.